Exploring the Potential of tsRNA as Biomarkers for Diagnosis and Treatment of Neurogenetic Disorders
- PMID: 40009263
- DOI: 10.1007/s12035-025-04760-5
Exploring the Potential of tsRNA as Biomarkers for Diagnosis and Treatment of Neurogenetic Disorders
Abstract
tRNA-derived small RNA (tsRNA) is a recently discovered small non-coding RNA (ncRNA) molecule that widely exists in prokaryotic and eukaryotic transcriptomes and is produced by specific cleavage of mature tRNA or precursor tRNA. In recent years, with the development of high-throughput sequencing technology, tsRNA has been found to have a variety of biological functions, including gene expression regulation, stress signal activation, etc. In addition, it has been found that these molecules are abnormally expressed in various diseases and participate in various pathological processes, which play an important role. At present, more and more studies have shown that the expression level of tsRNA changes significantly during the development of neurogenetic diseases. This review provides an overview of the classification and biological functions of tsRNAs, with a particular emphasis on their roles in neurogenetic disorders and their potential as diagnostic biomarkers and therapeutic targets. Despite the nascent stage of tsRNA research, their relevance to the diagnosis and treatment of neurogenetic diseases warrants further investigation.
Keywords: Biomarker; Mechanism; Neurogenetic Disorders; tsRNA.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
Similar articles
-
Emerging roles of transfer RNA fragments in the CNS.Brain. 2025 Aug 1;148(8):2631-2645. doi: 10.1093/brain/awaf130. Brain. 2025. PMID: 40294208 Free PMC article. Review.
-
tsRNA modifications: An emerging layer of biological regulation in disease.J Adv Res. 2025 Aug;74:403-414. doi: 10.1016/j.jare.2024.09.010. Epub 2024 Sep 10. J Adv Res. 2025. PMID: 39260796 Free PMC article. Review.
-
tRNA-derived small RNA 3' tRF-Ala CGC obstructs NK cytotoxicity via cleavage of membrane protein MICA in colorectal cancer.Front Immunol. 2025 Jul 14;16:1620550. doi: 10.3389/fimmu.2025.1620550. eCollection 2025. Front Immunol. 2025. PMID: 40726981 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
Cited by
-
Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions.Noncoding RNA Res. 2025 Jul 11;15:65-73. doi: 10.1016/j.ncrna.2025.07.003. eCollection 2025 Dec. Noncoding RNA Res. 2025. PMID: 40809958 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
